PDB Information

PDB6G5F
MethodX-RAY DIFFRACTION
Host OrganismEscherichia coli BL21(DE3)
Gene SourceClostridium botulinum
Primary Citation
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models.
Elliott, M., Favre-Guilmard, C., Liu, S.M., Maignel, J., Masuyer, G., Beard, M., Boone, C., Carre, D., Kalinichev, M., Lezmi, S., Mir, I., Nicoleau, C., Palan, S., Perier, C., Raban, E., Zhang, S., Dong, M., Stenmark, P., Krupp, J.
Sci Adv
HeaderToxin
Released2018-03-29
Resolution2.500
CATH Insert Date20 Jan, 2019

PDB Images (5)

PDB Prints

PDB Chains (3)

Chain ID Date inserted into CATH CATH Status
A 20 Jan, 2019 Chopped
B 20 Jan, 2019 Write scan list
P 20 Jan, 2019 Rejected

CATH Domains (1)

Domain ID Date inserted into CATH Superfamily CATH Status
6g5fA00 21 Jan, 2019 3.90.1240.10 Assigned

UniProtKB Entries (3)

Accession Gene ID Taxon Description
P10844 BXB_CLOBO Clostridium botulinum Botulinum neurotoxin type B
P21579 SYT1_HUMAN Homo sapiens Synaptotagmin-1
P10844 BXB_CLOBO Clostridium botulinum Botulinum neurotoxin type B
CATH-Gene3D is a Global Biodata Core Resource Learn more...